Consuelo Guardiola

Dr. Consuelo Guardiola

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2014 in Optics Letters
Verified
Journal Article
Open access
PDF file
ADArash Darafsheh
Arash Darafsheh
CGConsuelo Guardiola
Consuelo Guardiola
APAverie Palovcak
Averie Palovcak
JFJarod C. Finlay
Jarod C. Finlay
ACAlejandro Carabe
Alejandro Carabe
We demonstrated feasibility of super-resolution imaging through high-index microspheres embedded in transparent elastomers. We performed imaging, with resolution improvement by a factor of two, by using implanted barium titanate glass microspheres (diameters ∼30–150  μm and refractive index ∼1.9–2.1) in a thin film of polydimethylsiloxane elastomer placed over the specimen. Microsphere-assisted imaging technique is a promising candidate for applications in cancer research. As a proof-of-principle, we used microsphere-assisted imaging technique for the observation of radiation-induced γ-H2AX foci formation in U87 human glioblastoma cells irradiated by clinical proton beams.

31 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
yolanda prezadoyolanda prezado
yolanda prezado
GJGregory Jouvion
Gregory Jouvion
DHDavid Hardy
David Hardy
APAnnalisa Patriarca
Annalisa Patriarca
CNCatherine Nauraye
Catherine Nauraye
FPFrederic Pouzoulet
Frederic Pouzoulet
Proton minibeam radiation therapy (pMBRT) is a novel strategy for minimizing normal tissue damage resulting from radiotherapy treatments. This strategy partners the inherent advantages of protons for radiotherapy with the gain in normal tissue preservation observed upon irradiation with narrow, spatially fractionated beams. In this study, whole brains (excluding the olfactory bulb) of Fischer 344 rats (n = 16) were irradiated at the Orsay Proton Therapy Center. Half of the animals received standard proton irradiation, while the other half were irradiated with pMBRT at the same average dose (25 Gy in one fraction). The animals were followed-up for 6 months. A magnetic resonance imaging (MRI) study using a 7-T small-animal MRI scanner was performed along with a histological analysis. Rats treated with conventional proton irradiation exhibited severe moist desquamation, permanent epilation and substantial brain damage. In contrast, rats in the pMBRT group exhibited no skin damage, reversible epilation and significantly reduced brain damage; some brain damage was observed in only one out of the eight irradiated rats. These results demonstrate that pMBRT leads to an increase in normal tissue resistance. This net gain in normal tissue sparing can lead to the efficient treatment of very radio-resistant tumours, which are currently mostly treated palliatively.

10 September 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RMR. Alan Mitteer
R. Alan Mitteer
YWYanling Wang
Yanling Wang
JSJennifer Shah
Jennifer Shah
SGSherika Gordon
Sherika Gordon
MFMarcus Fager
Marcus Fager
YFYi Fan
Yi Fan
Glioblastoma multiforme (GBM) is among the most lethal of human malignancies. Most GBM tumors are refractory to cytotoxic therapies. Glioma stem cells (GSCs) significantly contribute to GBM progression and post-treatment tumor relapse, therefore serving as a key therapeutic target; however, GSCs are resistant to conventional radiation therapy. Proton therapy is one of the newer cancer treatment modalities and its effects on GSCs function remain unclear. Here, by utilizing patient-derived GSCs, we show that proton radiation generates greater cytotoxicity in GSCs than x-ray photon radiation. Compared with photon radiation, proton beam irradiation induces more single and double strand DNA breaks, less H2AX phosphorylation, increased Chk2 phosphorylation and reduced cell cycle recovery from G2 arrest, leading to caspase-3 activation, PARP cleavage and cell apoptosis. Furthermore, proton radiation generates a large quantity of reactive oxygen species (ROS), which is required for DNA damage, cell cycle redistribution, apoptosis and cytotoxicity. Together, these findings indicate that proton radiation has a higher efficacy in treating GSCs than photon radiation. Our data reveal a ROS-dependent mechanism by which proton radiation induces DNA damage and cell apoptosis in GSCs. Thus, proton therapy may be more efficient than conventional x-ray photon therapy for eliminating GSCs in GBM patients.

1 June 2019 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
yolanda prezadoyolanda prezado
yolanda prezado
GJGregory Jouvion
Gregory Jouvion
CGConsuelo Guardiola
Consuelo Guardiola
WGWilfredo Gonzalez
Wilfredo Gonzalez
MJMarjorie Juchaux
Marjorie Juchaux
RDRemi Dendale
Remi Dendale

7 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
yolanda prezadoyolanda prezado
yolanda prezado
GJGregory Jouvion
Gregory Jouvion
APAnnalisa Patriarca
Annalisa Patriarca
CNCatherine Nauraye
Catherine Nauraye
CGConsuelo Guardiola
Consuelo Guardiola
FPFrederic Pouzoulet
Frederic Pouzoulet
Proton minibeam radiation therapy (pMBRT) is a novel strategy which has already shown a remarkable reduction in neurotoxicity as to compared with standard proton therapy. Here we report on the first evaluation of tumor control effectiveness in glioma bearing rats with highly spatially modulated proton beams. Whole brains (excluding the olfactory bulb) of Fischer 344 rats were irradiated. Four groups of animals were considered: a control group (RG2 tumor bearing rats), a second group of RG2 tumor-bearing rats and a third group of normal rats that received pMBRT (70 Gy peak dose in one fraction) with very heterogeneous dose distributions, and a control group of normal rats. The tumor-bearing and normal animals were followed-up for 6 months and one year, respectively. pMBRT leads to a significant tumor control and tumor eradication in 22% of the cases. No substantial brain damage which confirms the widening of the therapeutic window for high-grade gliomas offered by pMBRT. Additionally, the fact that large areas of the brain can be irradiated with pMBRT without significant side effects, would allow facing the infiltrative nature of gliomas.

11 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
yolanda prezadoyolanda prezado
yolanda prezado
MSM. Dos Santos
M. Dos Santos
WGW. Gonzalez
W. Gonzalez
GJG. Jouvion
G. Jouvion
CGConsuelo Guardiola
Consuelo Guardiola
FPF. Pouzoulet
F. Pouzoulet
Minibeam radiation therapy (MBRT) is an innovative synchrotron radiotherapy technique able to shift the normal tissue complication probability curves to significantly higher doses. However, its exploration was hindered due to the limited and expensive beamtime at synchrotrons. The aim of this work was to develop a cost-effective equipment to perform systematic radiobiological studies in view of MBRT. Tumor control for various tumor entities will be addressable as well as studies to unravel the distinct biological mechanisms involved in normal and tumor tissues responses when applying MBRT. With that aim, a series of modifications of a small animal irradiator were performed to make it suitable for MBRT experiments. In addition, the brains of two groups of rats were irradiated. Half of the animals received a standard irradiation, the other half, MBRT. The animals were followed-up for 6.5 months. Substantial brain damage was observed in the group receiving standard RT, in contrast to the MBRT group, where no significant lesions were observed. This work proves the feasibility of the transfer of MBRT outside synchrotron sources towards a small animal irradiator.